KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Bristol Myers Squibb's Profit After Tax rose 8115.23% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year increase of 18342.07%. This contributed to the annual value of -$8.9 billion for FY2024, which is 21129.35% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Profit After Tax is $2.2 billion, which was up 8115.23% from $1.3 billion recorded in Q2 2025.
  • Bristol Myers Squibb's Profit After Tax's 5-year high stood at $2.5 billion during Q1 2025, with a 5-year trough of -$11.9 billion in Q1 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Profit After Tax value was $1.7 billion (recorded in 2024), while the average stood at $970.3 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Profit After Tax skyrocketed by 134823.53% in 2021, and later crashed by 62540.8% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Profit After Tax (Quarter) stood at $2.4 billion in 2021, then decreased by 14.63% to $2.0 billion in 2022, then dropped by 12.99% to $1.8 billion in 2023, then plummeted by 95.91% to $72.0 million in 2024, then skyrocketed by 2956.94% to $2.2 billion in 2025.
  • Its Profit After Tax was $2.2 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $2.5 billion in Q1 2025.